Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Widespread Tau-Specific CD4 T Cell Reactivity in the General Population.

Lindestam Arlehamn CS, Pham J, Alcalay RN, Frazier A, Shorr E, Carpenter C, Sidney J, Dhanwani R, Agin-Liebes J, Garretti F, Amara AW, Standaert DG, Phillips EJ, Mallal SA, Peters B, Sulzer D, Sette A.

J Immunol. 2019 May 13. pii: ji1801506. doi: 10.4049/jimmunol.1801506. [Epub ahead of print]

PMID:
31085590
2.

Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.

Chan RB, Perotte AJ, Zhou B, Liong C, Shorr EJ, Marder KS, Kang UJ, Waters CH, Levy OA, Xu Y, Shim HB, Pe'er I, Di Paolo G, Alcalay RN.

PLoS One. 2017 Feb 17;12(2):e0172348. doi: 10.1371/journal.pone.0172348. eCollection 2017.

3.

Automated parameter optimization in modeling absorption spectra and resonance Raman excitation profiles.

Shorr E, Myers Kelley A.

Phys Chem Chem Phys. 2007 Sep 14;9(34):4785-92. Epub 2007 Jul 6.

PMID:
17712457
5.
6.

Metabolic studies in paralytic acute anterior poliomyelitis. II. Alterations in calcium and phosphorus metabolism.

WHEDON GD, SHORR E.

J Clin Invest. 1957 Jun;36(6 Part 2):966-81. No abstract available.

7.

Metabolic studies in paralytic acute anterior poliomyelitis. I. Alterations in nitrogen and creatine metabolism.

WHEDON GD, SHORR E.

J Clin Invest. 1957 Jun;36(6 Part 2):941-65. No abstract available.

8.

Panel discussion on osteoporosis.

SHORR E, LASZLO D, SHOCK NW, WHEDON GD.

J Am Geriatr Soc. 1957 Apr;5(4):363-84. No abstract available.

PMID:
13428522
9.

Influence on hepatic ferritin systems of tertiary amine, G-D 131, with beneficial effects in shock.

BAEZ S, SRIKANTIA SG, SHORR E.

Proc Soc Exp Biol Med. 1956 May;92(1):61-5. No abstract available.

PMID:
13336074
10.

Mechanism of the catalytic oxidation of adrenaline by ferritin.

GREEN S, MAZUR A, SHORR E.

J Biol Chem. 1956 May;220(1):237-55. No abstract available.

11.

The oxidation of adrenaline by ferritin iron and hydrogen peroxide.

MAZUR A, GREEN S, SHORR E.

J Biol Chem. 1956 May;220(1):227-35. No abstract available.

12.

Circulatory homeostasis following massive injury, studies of vasodepressor and vasoexcitatory substances in the circulating blood.

SCOTT R Jr, HOWARD JM, SHORR E, LAWSON N, DAVIS JH.

Ann Surg. 1955 Apr;141(4):504-9. No abstract available.

13.

The mechanism of iron release from ferritin as related to its biological properties.

MAZUR A, BAEZ S, SHORR E.

J Biol Chem. 1955 Mar;213(1):147-60. No abstract available.

14.

Metabolic studies on the effects of crystalline growth hormone (somatotropin) in man.

SHORR E, CARTER AC, KENNEDY BJ, SMITH RW Jr.

Diabetes. 1954 Mar-Apr;3(2):94-8. No abstract available.

PMID:
13161728
15.

Intermediary metabolism and biological activities of ferritin.

SHORR E.

Harvey Lect. 1954-1955;50:112-53. No abstract available.

PMID:
13306036
16.

The emergence of psychological problems in patients requiring prolonged hospitalization.

SHORR E.

Tex Rep Biol Med. 1954;12(3):599-605. No abstract available.

PMID:
13216658
17.

Effects of inhibitors on calcium deposition in cartilage in vitro.

HIATT HH, MARKS PA, SHORR E.

J Biol Chem. 1953 Sep;204(1):187-95. No abstract available.

18.

Factors influencing deposition of calcium and strontium in cartilage in vitro.

MARKS PA, HIATT HA, SHORR E.

J Biol Chem. 1953 Sep;204(1):175-85. No abstract available.

19.

The influence of the adrenal cortex on behavior of terminal vascular bed.

ZWEIFACH BW, SHORR E, BLACK MM.

Ann N Y Acad Sci. 1953 Jul 17;56(4):626-33. No abstract available.

PMID:
13208053
20.

A microcolorimetric method for the determination of inorganic phosphorus.

TAUSSKY HH, SHORR E.

J Biol Chem. 1953 Jun;202(2):675-85. No abstract available.

21.

Influence of oxygen tension on tetrazolium reduction by epiphyseal cartilage of rachitic rats in vitro.

HIATT HH, SHORR E.

Proc Soc Exp Biol Med. 1953 Mar;82(3):543-6. No abstract available.

PMID:
13047459
22.

A simplified method for estimating urinary inorganic phosphate during aluminum gel therapy for phosphatic calculi.

TAUSSKY HH, SHORR E.

J Urol. 1953 Mar;69(3):454-5. No abstract available.

PMID:
13035938
23.

Metabolic studies on the effects of crystalline growth hormone (somatotropin) in man.

SHORR E, CARTER AC, KENNEDY BJ, SMITH RW Jr.

Trans Assoc Am Physicians. 1953;66:114-26; discussion, 127-8. No abstract available.

PMID:
13136254
24.

An attempt to assess the magnitude of endogenous androgen production in a case of the adrenogenital syndrome.

CARTER AC, SHORR E, TOSCANI V, STEVENS E, DAVIS VB.

J Clin Endocrinol Metab. 1952 Aug;12(8):1059-76. No abstract available.

PMID:
14946254
25.

The usefulness of strontium as an adjuvant to calcium in the remineralization of the skeleton in man.

SHORR E, CARTER AC.

Bull Hosp Joint Dis. 1952 Apr;13(1):59-66. No abstract available.

PMID:
14935450
26.

Relation of the sulhydryl groups in ferritin to its antidiuretic action.

MAZUR A, BAEZ S, SHORR E.

Am J Physiol. 1952 Apr;169(1):134-9. No abstract available.

PMID:
14923873
27.

Role of the neurohypophysis in ferritin-induced antidiuresis.

BAEZ S, MAZUR A, SHORR E.

Am J Physiol. 1952 Apr;169(1):123-33. No abstract available.

PMID:
14923872
28.

A renal factor in vascular response to hemorrhagic and traumatic shock.

BAEZ S, ZWEIFACH BW, PELLON R, SHORR E.

Am J Physiol. 1951 Sep;166(3):658-65. No abstract available.

PMID:
14885455
29.

The role of hepatorenal vasoactive factors in experimental shock, and in experimental renal and human essential hypertension.

SHORR E.

Trans Stud Coll Physicians Phila. 1951 Apr;19(1):14-24. No abstract available.

PMID:
14835785
30.

Evaluation of tetrazolium as a histochemical index of adrenal cortical activity.

ZWEIFACH BW, BLACK MM, SHORR E, METZ DB.

Proc Soc Exp Biol Med. 1951 Mar;76(3):446-54. No abstract available.

PMID:
14844236
31.

Histochemical studies with triphenyl tetrazolium of the kidney and adrenal cortex in experimental renal and human essential hypertension.

SHORR E, ZWEIFACH BW, BLACK MM, RATZERSDORFER C.

Trans Assoc Am Physicians. 1951;64:445-58. No abstract available.

PMID:
14884281
32.

Participation of VEM and VDM mechanisms in drum shock and in development of 'resistance' to drum trauma.

ZWEIFACH BW, METZ DB, SHORR E.

Am J Physiol. 1951 Jan;164(1):91-104. No abstract available.

PMID:
14810906
33.
34.

Aluminum gels in the management of renal phosphatic calculi.

SHORR E, CARTER AC.

J Am Med Assoc. 1950 Dec 30;144(18):1549-56. No abstract available.

PMID:
14794376
35.

A method for evaluating the relation of glycogen to inorganic salt deposition in surviving cartilage slices in vitro.

MARKS PA, SHORR E.

Science. 1950 Dec 22;112(2921):752-4. No abstract available.

PMID:
14798343
36.

Oxidation and reduction of ferritin sulfhydryl-disulfide groups by liver.

MAZUR A, LITT I, SHORR E.

J Biol Chem. 1950 Dec;187(2):497-510. No abstract available.

37.

The relation of sulfhydryl groups in ferritin to its vasodepressor activity.

MAZUR A, LITT I, SHORR E.

J Biol Chem. 1950 Dec;187(2):485-95. No abstract available.

38.

Chemical properties of ferritin and their relation to its vasodepressor activity.

MAZUR A, LITT I, SHORR E.

J Biol Chem. 1950 Dec;187(2):473-84. No abstract available.

39.

Histochemical alterations revealed by tetrazolium chloride in hypertensive kidneys in relation to renal VEM Mechanisms.

ZWEIFACH BW, BLACK MM, SHORR E.

Proc Soc Exp Biol Med. 1950 Aug;74(4):848-54. No abstract available.

PMID:
14781200
40.

Studies on VEM and VDM in blood in relation to renal hemodynamics and renal oxygen extraction in chronic congestive heart failure.

EDELMAN IS, ZWEIFACH BW, ESCHER DJ, GROSSMAN J, MOKOTOFF R, WESTON RE, LEITER L, SHORR E.

J Clin Invest. 1950 Jul;29(7):925-34. No abstract available.

41.

Hepatorenal factors in circulatory homeostasis. XX. Antidiuretic action of hepatic vasodepressor, VDM (ferritin).

BAEZ S, MAZUR A, SHORR E.

Am J Physiol. 1950 Jul 1;162(1):198-212. No abstract available.

PMID:
15432689
42.

Effect of anoxia on contractility and metabolism of intestinal smooth muscle.

FURCHGOTT RF, SHORR E.

Am J Physiol. 1950 Jul 1;162(1):88-98. No abstract available.

PMID:
15432674
43.

The antidiuretic action of the hepatic vasodepressor ferritin (VDM) and its occurrence in conditions associated with antidiuresis in man.

SHORR E, BAEZ S, ZWEIFACH BW, PAYNE MA, MAZUR A, METZ DB.

Trans Assoc Am Physicians. 1950;63:39-50. No abstract available.

PMID:
14855554
44.

Modification of the effects of immobilization upon metabolic and physiologic functions of normal men by the use of an oscillating bed.

WHEDON GD, DEITRICK JE, SHORR E.

Am J Med. 1949 Jun;6(6):684-711. No abstract available.

PMID:
18134065
45.
46.

The effect of succinate on respiration and certain metabolic processes of mammalian tissues at low oxygen tensions in vitro.

FURCHGOTT RF, SHORR E.

J Biol Chem. 1948 Aug;175(1):201-15. No abstract available.

PMID:
18873295
47.

A study of the biological activity and the magnitude of endogenous androgen production in a case of adrenogenital syndrome.

CARTER AC, SHORR E.

J Clin Endocrinol Metab. 1948 Jul;8(7):583. No abstract available.

PMID:
18939184
48.

Hepato-renal factors in circulatory hemeostasis; the influence of humoral factors of hepato-renal origin on the vascular reactions to hemorrhage.

SHORR E, ZWEIFACH BW, FURCHGOTT RF.

Ann N Y Acad Sci. 1948 May 11;49(Art 4):571-92. No abstract available.

PMID:
18915063
49.

Hepato-renal factors in circulatory homeostasis; vascular changes in mesentery in renal hypertension in rats.

ZWEIFACH BW, ROSENFELD S, SHORR E.

Fed Proc. 1948 Mar;7(1 Pt 1):139. No abstract available.

PMID:
18934675
50.

Hepato-renal factors in circulatory homeostasis; VEM and VDM mechanisms in nutritional cirrhosis in rats.

SHORR E, ZWEIFACH BW.

Fed Proc. 1948 Mar;7(1 Pt):115. No abstract available.

PMID:
18934522

Supplemental Content

Support Center